申请人:Sage Therapeutics, Inc.
公开号:US20170304321A1
公开(公告)日:2017-10-26
Methods for treating a subject suffering from a sterol synthesis disorder or a sterol deficiency disorder, e.g., Smith-Lemli-Opitz syndrome, the method comprising administering to the subject an effective amount of an NMDA receptor modulating compound, are provided.